Critical review of strategies to prevent and control iron deficiency in children

Food and Nutrition Bulletin

Volumn 28, Issue 4 SUPPL., 2007, Pages

  Lynch, Sean ^a,c   Stoltzfus, Rebecca ^b   Rawat, Rahul ^b  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b Cornell University ^*  (United States)

^c NONE   (United States)

Author keywords

Folic acid; Iron; Malaria; Supplementation

Indexed keywords

CHILD HEALTH; CONFERENCE PROCEEDING; CRITICAL ANALYSIS; DEVELOPING WORLD; FOOD SUPPLEMENTATION; HEALTH CARE; HEALTH RISK; MALARIA; MORBIDITY; NUTRITIONAL REQUIREMENT; STRATEGIC APPROACH; VITAMIN DEFICIENCY;

AFRICA; EAST AFRICA; PEMBA ISLAND; SUB-SAHARAN AFRICA; TANZANIA;

PLASMODIUM FALCIPARUM;

EID: 38549120242     PISSN: 03795721     EISSN: None     Source Type: Journal    
DOI: 10.1177/15648265070284s413     Document Type: Conference Paper

References (82)

1. Stoltzfus RJ, Dreyfuss ML. Guidelines for the use of iron supplements to prevent and treat iron deficiency anemia. Washington, DC: International Life Sciences Institute Press, 1998.
2. Sazawal S, Black RE, Ramsan M, Chwaya HM, Stoltzfus RJ, Dutta A, Dhingra U, Kabole I, Deb S, Othman MK, Kabole FM. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: Community-based, randomised, placebo-controlled trial. Lancet 2006;367:133-43.
3. Finch C. Regulators of iron balance in humans. Blood 1994; 84:1697-702.
4. Nemeth E, Ganz T. Regulation of iron metabolism by hepcidin. Annu Rev Nutr 2006;26:323-42.
5. Institute of Medicine. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academy Press, 2001.
6. Cook JD, Skikne BS, Lynch SR, Reusser ME. Estimates of iron sufficiency in the US population. Blood 1986; 68:726-31.
7. Lozoff B, De Andraca I, Castillo M, Smith JB, Walter T, Pino P. Behavioral and developmental effects of preventing iron-deficiency anemia in healthy full-term infants. Pediatrics 2003; 112:846-54.
8. Lozoff B, Jimenez E, Hagen J, Mollen E, Wolf AW. Poorer behavioral and developmental outcome more than 10 years after treatment for iron deficiency in infancy. Pediatrics 2000;105:E51.
9. Lozoff B, Jimenez E, Wolf AW. Long-term developmental outcome of infants with iron deficiency. N Engl J Med 1991;325:687-94.
10. Algarin C, Peirano P, Garrido M, Pizarro F, Lozoff B. Iron deficiency anemia in infancy: Long-lasting effects on auditory and visual system functioning. Pediatr Res 2003;53:217-23.
11. Viteri FE, Torun B. Anaemia and physical work capacity. In: Garby L, ed. Clinics in Haematology. Vol 3, No 3. London: WB Saunders, 1974:609-26.
12. Brutsaert TD, Hernandez-Cordero S, Rivera J, Viola T, Hughes G, Haas JD. Iron supplementation improves progressive fatigue resistance during dynamic knee extensor exercise in iron-depleted, nonanemic women. Am J Clin Nutr 2003;77:441-8.
13. Brownlie T, Utermohlen V, Hinton PS, Giordano C, Haas JD. Marginal iron deficiency without anemia impairs aerobic adaptation among previously untrained women. Am J Clin Nutr 2002;75:734-42.
14. Haas JD, Brownlie T. Iron deficiency and reduced work capacity: A critical review of the research to determine a causal relationship. J Nutr 2001;131(2S-2):676S-88S; discussion 688S-90S.
15. Hinton PS, Giordano C, Brownlie T, Haas JD. Iron supplementation improves endurance after training in iron-depleted, nonanemic women. J Appl Physiol 2000;88:1103-11.
16. Zhu YI, Haas JD. Iron depletion without anemia and physical performance in young women. Am J Clin Nutr 1997;66:334-41.
17. Zimmermann MB. Iron status influences the efficacy of iodine prophylaxis in goitrous children in Cǒte d'Ivoire. Int J Vitam Nutr Res 2002;72:19-25.
18. Kurtzhals JA, Addae MM, Akanmori BD, Dunyo S, Koram KA, Appawu MA, Nkrumah FK, Hviid L. Anaemia caused by asymptomatic Plasmodium falciparum infection in semi-immune African schoolchildren. Trans R Soc Trop Med Hyg 1999;93:623-7.
19. Wright RO, Tsaih SW, Schwartz J, Wright RJ, Hu H. Association between iron deficiency and blood lead level in a longitudinal analysis of children followed in an urban primary care clinic. J Pediatr 2003;142:9-14.
20. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803-11.
21. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F. Body iron stores and the risk of carotid atherosclerosis: Prospective results from the Bruneck study. Circulation 1997;96:3300-7.
22. Ford ES, Cogswell ME. Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care 1999; 22:1978-83.
23. Brock JH. Iron and the immune system. In: Bullen JJ, Griffiths E, eds. Iron and infection. Molecular, physiological and clinical aspects, 2nd ed. New York: John Wiley & Sons 1999:289-325.
24. Hershko C. Iron, infection and immune function. Proc Nutr Soc 1993;52:65-174.
25. Bullen JJ, Griffiths E. Iron-binding proteins and host defense. In: Bullen JJ, Griffiths E, eds. Iron and infection. Molecular, physiological and clinical aspects, 2nd ed. New York: John Wiley & Sons, 1999:327-68.
26. Kochan I. The role of iron in bacterial infections, with special consideration of host-tubercle bacillus interaction. Curr Top Microbiol Immunol 1973;60:1-30.
27. Brock JH. Iron in infection, immunity, inflammation and neoplasia. In: Brock JH, Halliday JW, Pippard MJ, Powell LW, eds. Iron metabolism in health and disease. London: W.B. Saunders, 1994:353-89.
28. Ward CG, Bullen JJ. Clinical and physiological aspects. In: Bullen JJ, Griffiths E. eds. Iron and infection. Molecular, physiological and clinical aspects, 2nd ed. New York. John Wiley & Sons, 1999:369-450.
29. Hershko C, Peto TE, Weatherall DJ. Iron and infection. Br Med J (Clin Res Ed) 1988;296:660-4.
30. Moyo VM, Gangaidzo IT, Gordeuk VR, Kiire CF, Macphail AP. Tuberculosis and iron overload in Africa: A review. Cent Afr J Med 1997;43:334-9.
31. Oppenheimer SJ. Iron and its relation to immunity and infectious disease. J Nutr 2001;131(2S-2):616S-33S; discussion 633S-5S.
32. Snow RW, Byass P, Shenton FC, Greenwood BM. The relationship between anthropometric measurements and measurements of iron status and susceptibility to malaria in Gambian children. Trans R Soc Trop Med Hyg 1991;85:584-9.
33. Nyakeriga AM, Troye-Blomberg M, Dorfman JR, Alexander ND, Bäck R, Kortok M, Chemtai AK, Marsh K, Williams TN. Iron deficiency and malaria among children living on the coast of Kenya. J Infect Dis 2004;190:439-47.
34. Nyakeriga AM, Williams TN, Marsh K,Wambua S, Perlmann H, Perlmann P, Grandien A, Troye-Blomberg M. Cytokine mRNA expression and iron status in children living in a malaria endemic area. Scand J Immunol 2005;61:370-5.
35. Nyakeriga MA, Troye-Blomberg M, Bereczky S, Perlmann H, Perlmann P, ElGhazali G. Immunoglobulin E (IgE) containing complexes induce IL-4 production in human basophils: Effect on Th1-Th2 balance in malaria. Acta Trop 2003;86:55-62.
36. Bothwell TH, Charlton RW, Cook J, Finch C. Iron metabolism in man. Oxford, UK: Blackwell Scientific Publications, 1979.
37. Cook JD, Finch CA, Smith NJ. Evaluation of the iron status of a population. Blood 1976;48:449-55.
38. World Health Organization/Centers for Disease Control and Prevention, Assessing iron status of populations. Geneva: WHO/CDC, 2005.
39. Mei Z, Cogswell ME, Parvanta I, Lynch S, Beard JL, Stoltzfus RJ, Grummer-Strawn LM. Hemoglobin and ferritin are currently the most efficient indicators of population response to iron interventions: An analysis of nine randomized controlled trials. J Nutr 2005;135:1974-80.
40. World Health Organization/UNICEF/United Nations University. Iron deficiency anemia: Assessment, prevention, and control. Geneva: WHO, 2001.
41. Beesley R, Filteau S, Tomkins A, Doherty T, Ayles H, Reid A, Ellman T, Parton S. Impact of acute malaria on plasma concentrations of transferrin receptors. Trans R Soc Trop Med Hyg 2000;94:295-8.
42. Thurnham DI, Mburu AS, Mwaniki DL, De Wagt A. Micronutrients in childhood and the influence of sub-clinical inflammation. Proc Nutr Soc 2005;64:502-9.
43. van den Broek NR, Letsky EA, White SA, Shenkin A. Iron status in pregnant women: Which measurements are valid? Br J Haematol 1998;103:817-24.
44. Stoltzfus RJ, Chwaya HM, Albonico M, Schulze KJ, Savioli L, Tielsch JM. Serum ferritin, erythrocyte protoporphyrin and hemoglobin are valid indicators of iron status of school children in a malaria-holoendemic population. J Nutr 1997;127:293-8.
45. Stoltzfus RJ, Chway HM, Montresor A,Tielsch JM, Jape JK, Albonico M, Savioli L. Low dose daily iron supplementation improves iron status and appetite but not anemia, whereas quarterly anthelminthic treatment improves growth, appetite and anemia in Zanzibari preschool children. J Nutr 2004; 134:348-56.
46. Cook JD, Flowers CH, Skikne BS. An assessment of dried blood-spot technology for identifying iron deficiency. Blood 1998;92:1807-13.
47. Stoltzfus RJ, Chwaya HM, Montresor A, Albonico M, Savioli L, Tielsch JM. Malaria, hookworms and recent fever are related to anemia and iron status indicators in 0- to 5-y old Zanzibari children and these relationships change with age. J Nutr 2000;130:1724-33.
48. Mockenhaupt FP, May J, Stark K, Falusi AG, Meyer CG, Bienzle U. Serum transferrin receptor levels are increased in asymptomatic and mild Plasmodium falciparum- infection. Haematologica 1999;84:869-73.
49. Labbe RF, Rettmer RL. Zinc protoporphyrin: A product of iron-deficient erythropoiesis. Semin Hematol 1989;26:40-6.
50. Labbe RF, Vreman HJ, Stevenson DK. Zinc protoporphyrin: A metabolite with a mission. Clin Chem 1999;45:2060-72.
51. Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood 2003;101:3359-64.
52. Gordeuk VR. African iron overload. Semin Hematol 2002;39:263-9.
53. Ekenved G, Norrby A, Sölvell L. Serum iron increase as a measure of iron absorption - Studies on the correlation with total absorption. Scand J Haematol Suppl 1976;28:31-49.
54. Ekenved G. Absorption from different types of iron tablets - Correlation between serum iron increase in total absorption of iron. Scand J Haematol Suppl 1976;28:51-63.
55. Hoppe M, Hulthén L, Hallberg L. Serum, iron concentration as a tool to measure relative iron absorption from elemental iron powders in man. Scand J Clin Lab Invest 2003;63:489-96.
56. Hoppe M, Hulthén L, Hallberg L. The validation of using serum iron increase to measure iron absorption in human subjects. Br J Nutr 2004;92:485-8.
57. Hoppe M, Hulthén L, Hallberg L. The relative bioavailability in humans of elemental iron powders for use in food fortification. Eur J Nutr 2006;45:37-44.
58. Mebrahtu T, Stoltzfus RJ, Chwaya HM, Jape JK, Savioli L, Montresor A, Albonico M, Tielsch JM. Low-dose daily iron supplementation for 12 months does not increase the prevalence of malarial infection or density of parasites in young Zanzibari children. J Nutr 2004;134:3037-41.
59. English M, Snow RW. Iron and folic acid supplementation and malaria risk. Lancet 2006;367:90-1.
60. Labbé RF, Dewanji A. Iron assessment tests: Transferrin receptor vis-à-vis zinc protoporphyrin. Clin Biochem 2004;37:165-74.
61. Labbé RF. Clinical utility of zinc protoporphyrin. Clin Chem 1992;38:2167-8.
62. Thomas WJ, Koenig HM, Lightsey AL, Green R. Free erythrocyte porphyrin:hemoglobin ratios, serum ferritin, and transferrin saturation levels during treatment of infants with iron-deficiency anemia. Blood 1977;49:455-62.
63. Hershko C, Konijn AM, Link G, Moreb J, Grauer F, Weissenberg E. Combined use of zinc protoporphyrin (ZPP), mean corpuscular volume and haemoglobin measurements for classifying microcytic RBC disorders in children and young adults. Clin Lab Haematol 1985;7:259-69.
64. Hirsch RE, Pulakhandam UR, Billett HH, Nagel RL. Blood zinc protoporphyrin is elevated only in sickle cell patients with low fetal hemoglobin. Am J Hematol 1991;36:147-9.
65. Tillyer ML, Tillyer CR. Zinc protoporphyrin assays in patients with alpha and beta thalassaemia trait. J Clin Pathol 1994;47:205-8.
66. Hinchliffe RF, Lilleyman JS, Steel GJ, Bellamy GJ. Usefulness of red cell zinc protoporphyrin concentration in the investigation of microcytosis in children. Pediatr Hematol Oncol 1995;12:455-62.
67. Graham EA, Felgenhauer J, Detter JC, Labbé RF. Elevated zinc protoporphyrin associated with thalassemia trait and hemoglobin E. J Pediatr 1996;129:105-10.
68. Harthoorn-Lasthuizen EJ, Lindemans J, Langenhuijsen MM. Combined use of erythrocyte zinc protoporphyrin and mean corpuscular volume in differentiation of thalassemia from iron deficiency anemia. Eur J Haematol 1998;60:245-51.
69. Harthoorn-Lasthuizen EJ, Lindemans J, Langenhuijsen MM. Influence of iron deficiency anaemia on haemoglobin A2 levels: Possible consequences for beta-thalassaemia screening. Scand J Clin Lab Invest 1999;59:65-70.
70. Harteveld CL, Rozendaal L, Blom NA, Lo-A-Njoe S, Akkerman N, Arkestijn S, Van Delft P, Giordano PC. Hb Oegstgeest [alpha104(G11)Cys→Ser (alpha1)]. A new hemoglobin variant associated with a mild alpha-thalassemia phenotype. Hemoglobin 2005;29:165-9.
71. Hastka J, Lasserre JJ, Schwarzbeck A, Strauch M, Hehlmann R. Washing erythrocytes to remove interferents in measurements of zinc protoporphyrin by front-face hematofluorometry. Clin Chem 1992;38:2184-9.
72. Mijares IA, Lopez P, Rosado JL, Cebrian A, Vera-Aguilar E, Alatorre J, Quintanilla-Vega MB, Rojas Garcia AE, Stoltzfus RJ, Cebrian ME, Garcia-Vargas GG. Delta-aminolevulinic acid dehydratase genotype and its relationship with blood lead and zinc protoporphyrin levels in lead-exposed children living in a smelter community in Northern Mexico. Toxicol Mech Methods 2006;16:1-7.
73. Williams TN, Mwangi TW, Wambua S, Peto TE, Weatherall DJ, Gupta S, Recker M, Penman BS, Uyoga S, Macharia A, Mwacharo JK, Snow RW, Marsh K. Negative epistasis between the malaria-protective effects of alpha+-thalassemia and the sickle cell trait. Nat Genet 2005;37:1253-7.
74. Mockenhaupt FP, Ehrhardt S, Gellert S, Otchwemah RN, Dietz E, Anemana SD, Bienzle U. Alpha(+)-thalassemia protects African children from severe malaria. Blood 2004;104:2003-6.
75. Clegg JB, Weatherall DJ. Thalassemia and malaria: New insights into an old problem. Proc Assoc Am Physicians 1999;111:278-82.
76. Allen SJ, O'Donnell A, Alexander ND, Alpers MP, Peto TE, Clegg JB, Weatherall DJ. Alpha+-Thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci USA 1997; 94:14736-41.
77. Wellems TE, Fairhurst RM. Malaria-protective traits at odds in Africa? Nat Genet 2005;37:1160-2.
78. Lynch SR, Stoltzfus RJ. Iron and ascorbic acid: Proposed fortification levels and recommended iron compounds. J Nutr 2003;133:2978S-84S.
79. Nestel P, Briend A, de Benoist B, Decker E, Ferguson E, Fontaine O, Micardi A, Nalubola R. Complementary food supplements to achieve micronutrient adequacy for infants and young children. J Pediatr Gastroenterol Nutr 2003;36:316-28.
80. Viteri FE. Iron supplementation as a strategy for the control of iron deficiency and ferropenic anemia. Arch Latinoam Nutr 1999;49(3 suppl 2):15S-22S.
81. Carter JY, Loolpapit MP, Lema OE, Tome JL, Nagelkerke NJ, Watkins WM. Reduction of the efficacy of antifolate antimalarial therapy by folic acid supplementation. Am J Trop Med Hyg 2005;73:166-70.
82. Mulenga M, Malunga P, Bennett S, Thuma P, Shulman C, Fielding K, Greenwood B. Folic acid treatment of Zambian children with moderate to severe malaria anemia. Am J Trop Med Hyg 2006;74:986-90.